G

Genfit SA

GNFT

4.25000
USD
0.1
(2.41%)
Market Open
Volume
3
EPS
0
Div Yield
0
P/E
15
Market Cap
294,947,315
Related Instruments
AAPL
-3.610
(-1.63%)
218.370 USD
AMZN
-3.000
(-1.60%)
183.990 USD
DIS
-0.640
(-0.68%)
93.050 USD
GOOGL
-0.710
(-0.41%)
170.760 USD
MSFT
-1.14
(-0.27%)
417.07 USD
NFLX
-3.53
(-0.56%)
624.46 USD
NVDA
-7.750
(-6.62%)
109.380 USD
SPOT
-7.39
(-2.15%)
336.59 USD
TSLA
-15.150
(-6.53%)
216.890 USD
News

Title: Genfit SA

Sector: Healthcare
Industry: Biotechnology
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.